Clinical Trial Information Request for Protocol 24-654 Title A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction with Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone